Abstract:The double-stranded DNA (dsDNA) sensor STING has been increasingly implicated in responses to "sterile" endogenous threats and pathogens without nominal DNA or cyclic di-nucleotide stimuli. Previous work showed an endoplasmic reticulum (ER) stress response, known as the unfolded protein response (UPR), activates STING. Herein, we sought to determine if ER stress generated a STING ligand, and to identify the UPR pathways involved. Induction of IFN-β expression following stimulation with the UPR inducer thapsigargin (TPG) or oxygen glucose deprivation required both STING and the dsDNA-sensing cyclic GMP-AMP synthase (cGAS). Furthermore, TPG increased cytosolic mitochondrial DNA, and immunofluorescence visualized dsDNA punctae in murine and human cells, providing a cGAS stimulus. N-acetylcysteine decreased IFN-β induction by TPG, implicating reactive oxygen species (ROS). However, mitoTEMPO, a mitochondrial oxidative stress inhibitor did not impact TPG-induced IFN. On the other hand, inhibiting the inositol requiring enzyme 1 (IRE1) ER stress sensor and its target transcription factor XBP1 decreased the generation of cytosolic dsDNA. iNOS upregulation was XBP1-dependent, and an iNOS inhibitor decreased cytosolic dsDNA and IFN-β, implicating ROS downstream of the IRE1-XBP1 pathway. Inhibition of the PKR-like ER kinase (PERK) pathway also attenuated cytoplasmic dsDNA release. The PERK-regulated apoptotic factor Bim was required for both dsDNA release and IFN-β mRNA induction. Finally, XBP1 and PERK pathways contributed to cytosolic dsDNA release and IFN-induction by the RNA virus, Vesicular Stomatitis Virus (VSV). Together, our findings suggest that ER stressors, including viral pathogens without nominal STING or cGAS ligands such as RNA viruses, trigger multiple canonical UPR pathways that cooperate to activate STING and downstream IFN-β via mitochondrial dsDNA release.

Non-canonical Activation of the DNA Sensing Adaptor STING by ATM and IFI16 Mediates NF-κB Signaling after Nuclear DNA Damage

STING-mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death

STING an essential trigger of DNA-mediated innate immune signaling. (P1258)

Potential cGAS-STING pathway functions in DNA damage responses, DNA replication and DNA repair

Loss of the DNA repair protein, polynucleotide kinase/phosphatase, activates the type 1 interferon response independent of ionizing radiation

Human DNA-PK activates a STING-independent DNA sensing pathway

DNA-PK controls cyclic dinucleotide-associated type I Interferon responses

Antagonism of the STING Pathway via Activation of the AIM2 Inflammasome by Intracellular DNA

NF-κB Activation Enhances STING Signaling by Altering Microtubule-Mediated STING Trafficking.

The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer

DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS-STING signalling

Temporal modulation of the NF-κB RelA network in response to different types of DNA damage

A non-canonical, interferon-independent signaling activity of cGAMP triggers DNA damage response signaling

DNA sensing via STING regulates autoimmunity and tumor immunity. (IRM5P.648)

Multiple unfolded protein response pathways cooperate to link cytosolic dsDNA release to stimulator of interferon gene activation

Multiple Unfolded Protein Response pathways cooperate to link cytosolic dsDNA release to Stimulator of Interferon Gene (STING) activation

STING enhances cell death through regulation of reactive oxygen species and DNA damage

At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment

Persistent DNA damage triggers activation of the integrated stress response to promote cell survival under nutrient restriction

Cutting Edge: DNA Sensing Via the STING Adaptor in Myeloid Dendritic Cells Induces Potent Tolerogenic Responses.

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.